Felix W Frueh

Summary

Affiliation: Medco Health Solutions
Country: USA

Publications

  1. doi request reprint On rat poison and human medicines: personalizing warfarin therapy
    Felix W Frueh
    Medco Research Institute, LLC, 7315 Wisconsin Avenue, Bethesda, MD 20814, USA
    Trends Mol Med 18:201-5. 2012
  2. doi request reprint 4th US FDA-Drug Information Association pharmacogenomics workshop, held 10-12 December, 2007
    Felix W Frueh
    Medco Health Solutions Inc, 14401 Falling Leaf Drive, Gaithersburg, MD 20878, USA
    Pharmacogenomics 10:111-5. 2009
  3. doi request reprint Back to the future: why randomized controlled trials cannot be the answer to pharmacogenomics and personalized medicine
    Felix W Frueh
    Medco Health Solutions, Inc, Bethesda, MD 20814, USA
    Pharmacogenomics 10:1077-81. 2009
  4. doi request reprint Real-world clinical effectiveness, regulatory transparency and payer coverage: three ingredients for translating pharmacogenomics into clinical practice
    Felix W Frueh
    R and D Personalized Medicine, Medco Health Solutions, Inc, Bethesda, MD 20814, USA
    Pharmacogenomics 11:657-60. 2010
  5. pmc The future of direct-to-consumer clinical genetic tests
    Felix W Frueh
    Medco Research Institute, Medco Health Solutions, Inc, Bethesda, Maryland 20814, USA
    Nat Rev Genet 12:511-5. 2011
  6. doi request reprint Considerations for safety pharmacogenetics in clinical practice
    Felix W Frueh
    Medco Research Institute, LLC, 7315 Wisconsin Avenue, Bethesda, USA
    Drug Discov Today 16:898-901. 2011
  7. doi request reprint Payer perspectives on pharmacogenomics testing and drug development
    Robert S Epstein
    Medco Health Solutions, Inc, 100 Parsons Pond Drive, Franklin Lakes, NJ 07417, USA
    Pharmacogenomics 10:149-51. 2009
  8. ncbi request reprint From pharmacogenetics to personalized medicine: a vital need for educating health professionals and the community
    Felix W Frueh
    Stepoutside Consulting, LLC, Gaithersburg, MD 20878, USA
    Pharmacogenomics 5:571-9. 2004

Collaborators

Detail Information

Publications8

  1. doi request reprint On rat poison and human medicines: personalizing warfarin therapy
    Felix W Frueh
    Medco Research Institute, LLC, 7315 Wisconsin Avenue, Bethesda, MD 20814, USA
    Trends Mol Med 18:201-5. 2012
    ....
  2. doi request reprint 4th US FDA-Drug Information Association pharmacogenomics workshop, held 10-12 December, 2007
    Felix W Frueh
    Medco Health Solutions Inc, 14401 Falling Leaf Drive, Gaithersburg, MD 20878, USA
    Pharmacogenomics 10:111-5. 2009
    ....
  3. doi request reprint Back to the future: why randomized controlled trials cannot be the answer to pharmacogenomics and personalized medicine
    Felix W Frueh
    Medco Health Solutions, Inc, Bethesda, MD 20814, USA
    Pharmacogenomics 10:1077-81. 2009
    ..Hence, we need to re-focus on approaches that are neither new nor unproven, but have been ignored over the last few decades...
  4. doi request reprint Real-world clinical effectiveness, regulatory transparency and payer coverage: three ingredients for translating pharmacogenomics into clinical practice
    Felix W Frueh
    R and D Personalized Medicine, Medco Health Solutions, Inc, Bethesda, MD 20814, USA
    Pharmacogenomics 11:657-60. 2010
    ....
  5. pmc The future of direct-to-consumer clinical genetic tests
    Felix W Frueh
    Medco Research Institute, Medco Health Solutions, Inc, Bethesda, Maryland 20814, USA
    Nat Rev Genet 12:511-5. 2011
    ..Should these tests be regulated? If so, who, if anyone, should communicate results to consumers?..
  6. doi request reprint Considerations for safety pharmacogenetics in clinical practice
    Felix W Frueh
    Medco Research Institute, LLC, 7315 Wisconsin Avenue, Bethesda, USA
    Drug Discov Today 16:898-901. 2011
    ..Although pharmacogenetic tests that can help to assess whether an individual patient's personal risk exist (safety pharmacogenetics), they are not always performed...
  7. doi request reprint Payer perspectives on pharmacogenomics testing and drug development
    Robert S Epstein
    Medco Health Solutions, Inc, 100 Parsons Pond Drive, Franklin Lakes, NJ 07417, USA
    Pharmacogenomics 10:149-51. 2009
    ..The panel was generally enthusiastic about the promise of the field to improve drug selection or dosing...
  8. ncbi request reprint From pharmacogenetics to personalized medicine: a vital need for educating health professionals and the community
    Felix W Frueh
    Stepoutside Consulting, LLC, Gaithersburg, MD 20878, USA
    Pharmacogenomics 5:571-9. 2004
    ..To effectively move pharmacogenetics into everyday medicine, it is therefore imperative for scientists and teachers in the field to take on the challenge of disseminating pharmacogenetic insights to a broader audience...